Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18800910 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | August 2024 | December 2024 | Allow | 4 | 1 | 0 | No | No |
| 18764943 | N-TERMINAL MODIFIER AGENTS AND BINDERS FOR TREATING AND ANALYZING PEPTIDES | July 2024 | July 2025 | Allow | 12 | 2 | 1 | Yes | No |
| 18764600 | EFFICIENTLY CHARACTERIZING PROTEIN-PROTEIN INTERACTIONS | July 2024 | October 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18659334 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | May 2024 | March 2025 | Allow | 10 | 0 | 0 | No | No |
| 18660053 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | May 2024 | June 2025 | Allow | 14 | 0 | 0 | No | No |
| 18610717 | METHODS AND COMPOSITIONS USING ONE-SIDED TRANSPOSITION | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18590738 | ARRAYS INCLUDING A RESIN FILM AND A PATTERNED POLYMER LAYER | February 2024 | April 2025 | Allow | 14 | 1 | 0 | No | No |
| 18409174 | METHODS, COMPOSITIONS, AND SYSTEMS FOR SPATIAL ANALYSIS OF ANALYTES IN A BIOLOGICAL SAMPLE | January 2024 | May 2025 | Allow | 16 | 1 | 0 | Yes | No |
| 18492069 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | October 2023 | November 2024 | Allow | 13 | 1 | 2 | Yes | No |
| 18355946 | SINGLE CELL ANALYSIS OF TRANSPOSASE ACCESSIBLE CHROMATIN | July 2023 | April 2025 | Allow | 21 | 2 | 0 | No | No |
| 18329296 | MAMMALIAN CELL LINE FOR PROTEIN PRODUCTION AND LIBRARY GENERATION | June 2023 | November 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 18190288 | NANOPORE DEVICE AND METHODS OF BIOSYNTHESIS USING SAME | March 2023 | January 2024 | Allow | 10 | 0 | 0 | No | No |
| 18178367 | METHODS, COMPOSITIONS, AND SYSTEMS FOR CAPTURING PROBES AND/OR BARCODES | March 2023 | December 2024 | Allow | 22 | 4 | 0 | No | No |
| 18099913 | PROBE SET FOR ANALYZING A DNA SAMPLE AND METHOD FOR USING THE SAME | January 2023 | June 2025 | Allow | 29 | 3 | 0 | Yes | No |
| 18055297 | Fusion Proteins Comprising an Engineered Knottin Peptide and Uses Thereof | November 2022 | December 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 18050912 | FLEXIBLE SUBSTRATES FOR NUCLEIC ACID SYNTHESIS | October 2022 | February 2025 | Abandon | 28 | 3 | 0 | Yes | No |
| 17899860 | High-Throughput Screening Methods to Identify Small Molecule Targets | August 2022 | May 2024 | Allow | 21 | 1 | 0 | No | No |
| 17816691 | METHODS AND SYSTEMS FOR MASK ALIGNMENT IN MANUFACTURING PROCESS OF ARRAYS | August 2022 | June 2025 | Abandon | 35 | 0 | 1 | No | No |
| 17690386 | METHOD FOR SYNTHESIZING DNA | March 2022 | November 2024 | Abandon | 32 | 1 | 1 | No | No |
| 17683059 | GENE SEQUENCING CHIP AND GENE SEQUENCING METHOD | February 2022 | April 2025 | Allow | 37 | 1 | 0 | No | No |
| 17624295 | BIOMARKERS FOR IRRITABLE BOWEL SYNDROME | December 2021 | May 2025 | Allow | 40 | 0 | 0 | No | No |
| 17447416 | MODULAR CHEMIRESISTIVE SENSOR FOR REAL-TIME ETHYLENE MONITORING | September 2021 | April 2025 | Allow | 43 | 0 | 0 | No | No |
| 17431193 | METHODS FOR DETERMINING KINETIC PARAMETERS OF A REACTION BETWEEN ANALYTE AND LIGANDS | August 2021 | June 2025 | Allow | 46 | 0 | 1 | Yes | No |
| 17175606 | METHODS AND DEVICES FOR DETECTION AND ACQUISITION OF BIOMARKERS | February 2021 | January 2025 | Abandon | 48 | 1 | 0 | No | No |
| 17258001 | METHODS AND COMPOSITIONS FOR ANALYZING PLATELETS BY MASS CYTOMETRY | January 2021 | November 2024 | Abandon | 46 | 1 | 0 | No | No |
| 17141682 | Methods, Systems and Compositions Thereof for Nucleic Acid Library Quality Control and Quantification | January 2021 | May 2025 | Abandon | 52 | 4 | 1 | No | No |
| 17055803 | Devices, Systems, and Methods of Electronic Modulation of Polymerase for DNA Synthesis | November 2020 | August 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 17082940 | METHODS OF SINGLE-POLYPEPTIDE SEQUENCING AND RECONSTRUCTION | October 2020 | November 2024 | Abandon | 48 | 2 | 1 | No | No |
| 17079959 | COMPOSITIONS AND METHODS FOR THERAPEUTICS PRESCREENING | October 2020 | March 2025 | Allow | 53 | 5 | 0 | Yes | No |
| 16968512 | ARRAY-BASED CYCLIC PEPTIDE LIBRARIES | August 2020 | November 2024 | Abandon | 52 | 6 | 0 | No | No |
| 16943067 | STABILIZED IMMUNOGLOBULIN DOMAINS | July 2020 | November 2024 | Allow | 52 | 1 | 1 | No | No |
| 16548143 | IN VITRO DNA WRITING FOR INFORMATION STORAGE | August 2019 | November 2024 | Abandon | 60 | 4 | 1 | Yes | No |
| 16385735 | MOVABLE TYPE METHOD APPLIED TO PROTEIN-LIGAND BINDING | April 2019 | September 2024 | Allow | 60 | 1 | 0 | Yes | No |
| 16302345 | METHODS FOR IDENTIFICATION OF SAMPLES | November 2018 | January 2025 | Allow | 60 | 8 | 0 | Yes | No |
| 16074128 | NUCLEIC ACIDS ENCODING CHIMERIC POLYPEPTIDES FOR LIBRARY SCREENING | July 2018 | April 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 15212215 | METHODS OF SELECTING ANTIBODIES AND ANTIBODY FRAGMENTS | July 2016 | May 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 15131101 | APPARATUS FOR ASSAY, SYNTHESIS AND STORAGE, AND METHODS OF MANUFACTURE, USE, AND MANIPULATION THEREOF | April 2016 | January 2018 | Allow | 21 | 2 | 0 | Yes | No |
| 14993792 | PHAGE MICROARRAY PROFILING OF THE HUMORAL RESPONSE TO DISEASE | January 2016 | April 2018 | Allow | 27 | 0 | 1 | Yes | No |
| 14823571 | MANIPULATION OF MICROPARTICLES IN MICROFLUIDIC SYSTEMS | August 2015 | January 2017 | Allow | 18 | 1 | 0 | Yes | No |
| 14414916 | MULTI-SENSOR ARRAY COMPOUND AND METHODS OF USE THEREOF | January 2015 | January 2018 | Allow | 36 | 1 | 1 | Yes | No |
| 14073653 | PS-SPCL SEARCHING APPARATUS AND METHOD USING SURFACE PLASMON RESONANCE | November 2013 | April 2018 | Allow | 53 | 2 | 1 | No | No |
| 13761968 | TYROSINE KINASE BIOSENSORS AND METHODS OF USE | February 2013 | August 2016 | Allow | 43 | 3 | 1 | No | No |
| 13487605 | PROBE ARRAY BASE, METHOD FOR MANUFACTURING PROBE ARRAY BASE, METHOD FOR MANUFACTURING PROBE ARRAY | June 2012 | January 2014 | Allow | 19 | 2 | 1 | Yes | No |
| 13463212 | BETA-AMINO ACIDS | May 2012 | February 2014 | Allow | 21 | 1 | 1 | Yes | No |
| 13396352 | Methods and Compositions for the Target-localized Anchoring of Detectable Label | February 2012 | June 2016 | Allow | 52 | 4 | 1 | Yes | No |
| 13365554 | METHODS AND KITS USING EXTENDED RHODAMINE DYES | February 2012 | August 2013 | Allow | 19 | 2 | 2 | Yes | No |
| 13289542 | Ligand Libraries for Screening GPCRs | November 2011 | January 2013 | Abandon | 14 | 1 | 1 | No | No |
| 13207486 | IDENTIFYING ANTIGEN CLUSTERS FOR MONITORING A GLOBAL STATE OF AN IMMUNE SYSTEM | August 2011 | December 2013 | Allow | 28 | 1 | 1 | Yes | No |
| 12928312 | High throughput system for isolation, growth, and detection of lipid inclusions in bacteria | December 2010 | August 2015 | Allow | 56 | 2 | 1 | Yes | No |
| 12848888 | Stamping Apparatus For Biochips and Method For Operation Thereof | August 2010 | May 2015 | Allow | 58 | 2 | 1 | Yes | No |
| 12465719 | NOVEL DIARYLPHOSPHINE-CONTAINING COMPOUNDS, PROCESSES OF PREPARING SAME AND USES THEREOF AS TRIDENTATE LIGANDS | May 2009 | March 2013 | Allow | 46 | 2 | 1 | Yes | No |
| 12162799 | Novel Silane Compounds and Their Use in Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | August 2008 | July 2016 | Allow | 60 | 6 | 1 | No | No |
| 11884066 | Method and Array for the Replication and Analysis of Nucleic Acids | June 2008 | September 2015 | Allow | 60 | 4 | 2 | Yes | No |
| 12133190 | MASSIVELY PARALLEL SYNTHESIS OF BIOPOLYMERIC ARRAYS | June 2008 | July 2016 | Allow | 60 | 3 | 1 | No | No |
| 11908223 | QUANTUM DOT TEMPLATE FOR FAST AND SIMULTANEOUS DETECTION OF DIFFERENT INFECTIOUS AGENTS | May 2008 | December 2013 | Allow | 60 | 3 | 2 | Yes | No |
| 11856099 | METHOD AND COMPOSITION FOR DETECTING PROTEIN-PROTEIN AND PROTEIN-NUCLEIC ACID INTERACTIONS | September 2007 | September 2013 | Allow | 60 | 2 | 1 | Yes | No |
| 10594182 | POLYMER PARTICLE | July 2007 | December 2010 | Allow | 51 | 1 | 1 | Yes | No |
| 11758735 | METHOD FOR DETECTING TARGET BIOLOGICAL MATERIAL USING DNA BARCODES | June 2007 | November 2010 | Allow | 41 | 1 | 1 | Yes | No |
| 11744112 | NUCLEIC ACID SAMPLE PURIFICATION AND ENRICHMENT WITH A THERMO-AFFINITY MICROFLUIDIC SUB-CIRCUIT | May 2007 | March 2011 | Allow | 46 | 2 | 2 | Yes | No |
| 11404807 | METHOD FOR SCREENING ANTI-ADHERENT COMPOUNDS ON POLYMERS FOR PREVENTING BIOFILM FORMATION | April 2006 | June 2009 | Allow | 38 | 3 | 1 | Yes | No |
| 10563463 | CUCURBITURIL DERIVATIVE-BONDED SOLID SUBSTRATE AND BIOCHIP USING THE SAME | January 2006 | July 2010 | Allow | 54 | 3 | 1 | No | No |
| 10894916 | SOLUTION AND SOLID PHASE SYNTHESIS OF PYRROLINONES AND POLYPYRROLINONES | July 2004 | March 2010 | Allow | 60 | 5 | 0 | Yes | No |
| 10889914 | PREPARATION AND USES FOR POLYARYLATES | July 2004 | May 2009 | Allow | 58 | 3 | 1 | Yes | Yes |
| 10877380 | SEPARATION OF COMPOUNDS USING TAGGING MOIETIES INCLUDING VARYING NUMBERS OF REPEAT UNITS | June 2004 | April 2010 | Allow | 60 | 3 | 1 | Yes | No |
| 10838911 | FACILITATED FORWARD CHEMICAL GENETICS USING TAGGED TRIAZINE LIBRARY | May 2004 | February 2010 | Allow | 60 | 6 | 1 | Yes | No |
| 10779421 | HIGH THROUGHPUT SCREENING METHODS FOR LUBRICATING OIL COMPOSITIONS | February 2004 | February 2011 | Allow | 60 | 4 | 1 | Yes | Yes |
| 10470296 | END GROUP ACTIVATED POLYMERS WITH OLIGONUCLEOTIDE LIGANDS | July 2003 | August 2009 | Allow | 60 | 5 | 1 | Yes | No |
| 10466124 | PERFLUORO SULFONYL HALIDES AND RELATED SPECIES AS POLYMER SUPPORT MODIFIERS | July 2003 | November 2009 | Allow | 60 | 3 | 1 | Yes | Yes |
| 10612298 | PEPTIDES COMPRISING AROMATIC D-AMINO ACIDS AND METHODS OF USE | July 2003 | November 2009 | Allow | 60 | 6 | 1 | Yes | No |
| 10455986 | MULTI-CHANNEL ANALYTE-SEPARATION DEVICE EMPLOYING SIDE-ENTRY EXCITATION | June 2003 | January 2008 | Allow | 56 | 3 | 1 | Yes | No |
| 10417543 | METHODS FOR MEASURING ENZYME ACTIVITY | April 2003 | December 2009 | Allow | 60 | 4 | 1 | Yes | Yes |
| 10389501 | DURABLE FILM COATING COMPOSITIONS HAVING SUSTAINED SLOW-RELEASE CAPABILITY, AND METHODS OF USE THEREFOR | March 2003 | January 2008 | Abandon | 59 | 10 | 0 | Yes | Yes |
| 10253493 | INSULIN AND IGF-1 RECEPTOR AGONISTS AND ANTAGONISTS | September 2002 | January 2006 | Allow | 40 | 0 | 1 | Yes | No |
| 10197115 | LATEX BASED ADSORBENT CHIP | July 2002 | January 2009 | Allow | 60 | 4 | 2 | Yes | Yes |
| 10192026 | SURFACE PLASMON RESONANCE IMAGING OF MICRO-ARRAYS | July 2002 | November 2009 | Allow | 60 | 8 | 2 | Yes | No |
| 10186783 | SYNTHESIS AND USE OF ORGANOSILICA PARTICLES | July 2002 | September 2004 | Abandon | 27 | 6 | 1 | Yes | Yes |
| 10128493 | GLYCOSYL-ETOPOSIDE PRODRUGS, A PROCESS FOR PREPARATION THEREOF AND THE USE THEREOF IN COMBINATION WITH FUNCTIONALIZED TUMOR-SPECIFIC ENZYME CONJUGATES | April 2002 | July 2005 | Allow | 39 | 1 | 1 | No | No |
| 09908518 | LATEX BASED ADSORBENT CHIP | July 2001 | November 2008 | Allow | 60 | 7 | 2 | Yes | No |
| 09763607 | METHOD AND DEVICE FOR PRODUCING AND/OR ANALYZING BIOCHEMICAL REACTION SUPPORTING MATERIALS | April 2001 | January 2010 | Allow | 60 | 5 | 2 | Yes | No |
| 09764163 | CIRCULARLY PERMUTATED, INTERACTION-ACTIVATED PROTEINS | January 2001 | January 2009 | Allow | 60 | 7 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GROSS, CHRISTOPHER M.
With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 36.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner GROSS, CHRISTOPHER M works in Art Unit 1684 and has examined 72 patent applications in our dataset. With an allowance rate of 83.3%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 51 months.
Examiner GROSS, CHRISTOPHER M's allowance rate of 83.3% places them in the 51% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by GROSS, CHRISTOPHER M receive 2.93 office actions before reaching final disposition. This places the examiner in the 94% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by GROSS, CHRISTOPHER M is 51 months. This places the examiner in the 0% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +28.4% benefit to allowance rate for applications examined by GROSS, CHRISTOPHER M. This interview benefit is in the 79% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.5% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 16.7% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 59% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 70.0% are granted (fully or in part). This grant rate is in the 87% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 27.8% of allowed cases (in the 100% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.